Pulse Biosciences, Inc.

Pulse Biosciences, Inc. is a clinical-stage bioelectric medicine company based in Hayward, California. The company focuses on developing innovative medical technologies that utilize nanosecond pulsed electric fields for therapeutic purposes. Its core technology, Nanosecond Pulsed Field Ablation (nsPFA), delivers ultra-short electrical pulses to selectively ablate targeted cells without the use of drugs or heat, providing a local and drug-free treatment option. Pulse Biosciences markets its technology under the brand names CellFX and nsPFA, with applications in various medical fields such as cardiology, dermatology, oncology, minimally invasive therapies, aesthetics, and veterinary medicine. The CellFX system is designed for precise tissue ablation, enhancing treatment outcomes while minimizing collateral damage. The company is dedicated to health innovation and improving patient quality of life, employing around 56 people and reporting revenues of approximately $14 million. Pulse Biosciences is publicly traded under the symbol PLSE and is recognized for its strong company culture and employee satisfaction.

• Employees75
• Founded2016
• Annual Revenue$1664000
• Total Funding$63040002